Vanguard Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
2017
Q4
$429K Buy
2017
Q3
$572K Buy
2017
Q2
$756K Sell
2017
Q1
$1.93M Buy
2016
Q4
$520K Sell
2016
Q3
$1.36M Sell
2016
Q2
$1.85M Sell
2016
Q1
$4.28M Buy
2015
Q4
$10.4M Buy
2015
Q3
$9.7M Buy
2015
Q2
$22.4M Buy
2015
Q1
$29.7M Buy
2014
Q4
$22.2M Sell
2014
Q3
$15.9M Buy
2014
Q2
$18.5M Buy
2014
Q1
$19.2M Buy
2013
Q4
$15.6M Buy
2013
Q3
$15.6M Buy
2013
Q2
$13M Buy